COMING NEXT:

• BPEP is resuming its series of events online with the first one on July 16th. Join us on 16th July (4:30 - 6:30pm) for our online event “Innovate”. The event will include an introduction of BPEP, the Start-up Sponsorship Program and a panel discussion with current postdocs on their expectations from BPEP.
• Registration link: https://tinyurl.com/y9y5e591

• We are happy to announce the launch of a scholarship program to Postdocs and Visiting Scholars (VSPA affiliates) to explore launching startups that are based on research produced at UC Berkeley. The scholarship ($500) will help access resources provided by qb3 Startup in a box program. From incorporation to operation to growth, this program provides support and resources to entrepreneurs, in addition to access to their SBIR workshops. This scholarship program is limited to UC Berkeley VSPA affiliates with active appointments, who have a Ph.D. degree. Additional preference will be given to applicants who demonstrate their service to the entrepreneurial community at UC Berkeley. The scholarship program is enabled by a generous sponsorship by the Visiting Scholars and Postdoctoral Affairs Program (VSPA). Thanks to Yvette Lane-Newton, the Director of the VSPA , who has been instrumental in making this happen.
• Link to application: https://forms.gle/bZcLMd6FEYnE58Gy6

• We are extremely pleased to announce that Bacchus Therapeutics, founded by Arvin Gouw (Former Chair, BPEP) has been awarded the AbbVie Golden Ticket. Bacchus Therapeutics is a biotech company developing novel compounds that exploit cancer's hypermetabolic state by targeting cancer-specific metabolic pathways. Their proprietary compounds cause regression of incurable MYC cancers and prolong survival in our preclinical mouse models bearing human tumors.